Please Note: Blog posts are not selected, edited or screened by Seeking Alpha editors.

OREX doubles on FDA approval. We already had it!

|Includes: Orexigen Therapeutics, Inc. (OREX)
OREX (Orexigen Therapeutics, Inc) was chosen by none other than Rowan Jenkins, Chief Investor of Ivy Investment Group, 3 weeks ago.

The FDA approved its diet pill today and the shares soared over 100%.  The best part is that our investors already had the stock in their portfolios.

If investors want to be with a true winner, then choose Ivy Investment Group at

Maurice Ivy
Senior Partner
Ivy, Whitfield, and Associates, G.P.